Bladder Cancer Drug Market Insights: Tracking Uptake

Brief:

We conducted a 3-wave monthly tracker study for a major Pharma company, aimed at tracking the uptake of a competitor's new product in the European market.

Countries:

EU

Methodology:

Quantitative: 3x monthly trackers with Oncologists and Urologists

The research explored:

The primary focus was on monitoring the competitor's new product adoption and healthcare professionals' perceptions.

Delivered:

medintel executed a comprehensive and meticulously planned survey initiative. This included consistent surveys conducted every month across multiple markets. The approach was adaptable, taking into account launch timelines as needed, and ensuring minimal overlap between survey waves.

In addition, we diligently managed specific quotas established for Oncologists and urologists in each market. Our team proactively identified and engaged participants during the survey process, ensuring a dynamic and diverse dataset. This meticulous approach guaranteed that the research data collected was highly representative and accurate, providing our client with a robust dataset for their analysis and decision-making.